Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Reports Drop in Revenues

NEW YORK, April 30 -- Nanogen reported revenues of $1.2 million for the first quarter ending March 31, down from $1.5 million for the same quarter last year.


The San Diego-based company commercializing the Nanochip assay platform recorded the sale of a partial system and revenues from the sale of cartridges and reagents for product revenues of $228,000, compared to $812,000 for the same quarter last year.


The company reported a net loss of $10.7 million, compared with a net loss of $7.5 million for the prior year's first quarter. It spent $4.7 million on research and development in the quarter, compared to $4.8 million for the year-ago quarter.


Nanogen reported $36.9 million in cash, cash equivalents and short-term investments as of March 31.


The company also reported that it some of the shares it holds of CombiMatrix Corporation, Acacia Research's majority-owned subsidiary, to generate $4.5 million in cash. The shares, acquired in a settlement of a patent dispute, were valued at $2.70 a share. Nanogen sold 3 million shares at $1.50 a share to raise $4.5 million in operating cash reserves, the company said. The company recorded a loss of $3.6 million on the sale.


The company said it expects to see savings of approximately $5 million in operating expenses in fiscal year 2003, after charges of approximately $500,000 associated with a layoff of 20 percent of its staff are recognized in the second quarter.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.